Actos Lawsuits… Because a Diabetes Medication May Come With Side Effects
As per reports reflected on the website EHealthMe, a study dated August 17, 2011 on Actos side effects and bladder cancer risk, there are 22,512 reported side effects in taking Actos. Of these, 0.22% has acquired bladder cancer. The largest concentration of the data – about 43% – were using Actos between 2-5 years duration before developing cancer of the bladder. The next largest concentration –approx. 29% — was under Actos medication between 1-6 months duration.
As reported, the Type 2 Diabetes drug Actos (a.k.a piogliatazone) had its sales suspended in June 2011, by French and German medical regulators. This was brought by possible risks of bladder cancer. The decision in banning the drug is supported by a study commissioned by the French Medicines Agency. The study found that patients taking Actos were more prone to bladder cancer, one form of cancer that is thought aggressive. The study surveyed cancer rates involving 155,000 individuals under Actos medication in France between 2006 to 2009. The survey also includes 1.3 million other diabetics who were not taking the subject drug. The study resulted in about a 22 percent higher risk of bladder cancer among Actos takers in comparison to diabetics under other drugs. The risk of bladder cancer was highest among patients receiving a total dosage of 28,000 mg or more during the study period.
In the US, Food & Drug Administration (FDA) announced that it was reviewing Actos for a possible bladder cancer risk in September 2010. During that time, the agency stated that early data from a 10-year study conducted by Actos maker, Takeda, did not indicate a significant number that associates exposure to the drug with risk of bladder cancer. Nonetheless, evidence showed that patients under Actos medication for at least two years or at the highest cumulative doses of more than 28,000 mg are exposed to a greater danger of bladder cancer.
In May 2011, another study was conducted that reports to the FDA, between 2004-2009, manifesting “disproportionate risk” of bladder cancer among Actos takers. The study examined about half million adverse cases associated with various diabetes medications. It found that a fifth of those involving bladder cancer occurred in patients using Actos.
The risks that Actos poses to its users are cause for great alarm. And it is but right that those who found themselves affected by the drug consider filing an Actos lawsuit as they fight for their right for just compensation.
Processing your request, Please wait....
